Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1939]
News [3134]
Articles [127]
Editorials [3]
Conferences [119]
elearning [13]
New research linking cancer-inhibiting proteins to cell antennae
New research linking cancer-inhibiting proteins to cell antennae
Patients with HIV-associated lymphoma can safely continue anti-retroviral therapy during chemotherapy
Patients with HIV-associated lymphoma can safely continue anti-retroviral therapy during chemotherapy
ASH 2017: Study identifies agent that can reverse resistance to targeted drug in some leukaemia
ASH 2017: Study identifies agent that can reverse resistance to targeted drug in some leukaemia
New discovery may enhance chemotherapy's efficiency against leukaemia
New discovery may enhance chemotherapy's efficiency against leukaemia
ASH 2017: Targeted leukaemia drug venetoclax found superior to standard chemotherapy for broad range of patients when combined with rituximab
ASH 2017: Targeted leukaemia drug venetoclax found superior to standard chemotherapy for broad range of patients...
ASH 2017: Largest-ever trial shows direct oral anticoagulants are a viable option for treating blood clots in patients with cancer
ASH 2017: Largest-ever trial shows direct oral anticoagulants are a viable option for treating blood clots in...
ASH 2017: Trial supports addition of daratumumab to standard treatment regimen for patients with multiple myeloma
ASH 2017: Trial supports addition of daratumumab to standard treatment regimen for patients with multiple myeloma
ASH 2017: AML study reports high response rates with combination targeted therapy
ASH 2017: AML study reports high response rates with combination targeted therapy
ASH 2017: Responses to CAR T-cell therapy still strong after one year in patients with refractory NHL
ASH 2017: Responses to CAR T-cell therapy still strong after one year in patients with refractory NHL
ASH 2017: Six-month analysis of tisagenlecleucel in stubborn form of lymphoma shows sustained responses
ASH 2017: Six-month analysis of tisagenlecleucel in stubborn form of lymphoma shows sustained responses

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation